NCT06545604 Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer
| NCT ID | NCT06545604 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Ovarian Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-06-06 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-06-06 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To provide a comprehensive yoga therapy (CYT) program to patients with ovarian, fallopian tube, or primary peritoneal cancer who are scheduled to receive chemotherapy and then undergo surgery. Researchers want to learn about the effects of the program on patients' quality of life and other outcomes described below.
Eligibility Criteria
Inclusion Criteria: 1. Women with stage III-IV epithelial ovarian, fallopian tube, primary peritonal cancer with recommendations for NACT/IDS at recruitment. 2. Able to read, write, and speak English. 3. 18 years of age or older. 4. Oriented to person, place, and time. 5. Access to internet connection. 6. Access to a tablet, laptop or computer or smart phone. 7. Access and ability to do virtual sessions. 9\. Plan for surgical intervention at MD Anderson Cancer Center 9. Performance status 0-2. Exclusion Criteria: 1. Have completed chemotherapy. 2. Any major thought disorder (e.g., schizophrenia, dementia). 3. Any major communication barriers that would preclude being able to complete the intervention (e.g., visually or hearing impaired). 4. Extreme mobility issues (e.g., unable to get in and out of a chair unassisted). 5. Have a regular mind-body practice or an established yoga practice.
Contact & Investigator
Lois Ramondetta, MD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT06545604 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Ovarian Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06545604 currently recruiting?
Yes, NCT06545604 is actively recruiting participants. Contact the research team at lramonde@mdanderson.org for enrollment information.
Where is the NCT06545604 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06545604 clinical trial?
NCT06545604 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Lois Ramondetta, MD at M.D. Anderson Cancer Center. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.